Background & Aims: A significant proportion of Lynch syndrome cases are believed to be due to large genomic alterations in the mismatch repair genes hMLH1 and hMSH2. However, previous studies have not adequately identified the frequency and scope of such mutations, and routine clinical Lynch syndrome testing often does not include analysis for these mutations. Our aim was to characterize hMLH1 and hMSH2 genomic rearrangements in a large population of suspected Lynch syndrome patients.
Methods: A total of 365 samples from probands referred for genetic testing for Lynch syndrome were analyzed for the presence of large genomic alterations in hMLH1 or hMSH2 by using a combination of techniques. Samples with a deletion in exons 1-6 in hMSH2 were further characterized by polymerase chain reaction to establish the presence of the hMSH2 American founder deletion.
Results: An hMLH1 or hMSH2 mutation was identified in 153 cases, and, of these, 12 of 67 (17.9%) and 39 of 86 (45.3%) had a large genomic alteration in hMLH1 and hMSH2, respectively. Overall, 6 different hMLH1 and 12 different hMSH2 deletions/duplications, including 10 novel mutations, were identified. Analysis of the hMSH2 exon 1-6 deletion samples showed that 13 of 18 (72.2%) had the American founder deletion.
Conclusions: These data show a high frequency and diverse spectrum of large genomic alterations in hMLH1 and hMSH2 in suspected Lynch syndrome patients. Thus, a comprehensive mutation identification strategy that includes the ability to detect large genomic rearrangements is imperative for the clinical genetic identification of Lynch syndrome patients and families.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1053/j.gastro.2005.06.026 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
BRAF immunohistochemistry can reliably substitute BRAF molecular testing in the Lynch syndrome screening algorithm in colorectal cancer.
Histopathology
April 2024
IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Aims: The Lynch syndrome (LS) screening algorithm requires BRAF testing as a fundamental step to distinguish sporadic from LS-associated colorectal carcinomas (CRC). BRAF testing by immunohistochemistry (IHC) has shown variable results in the literature. Our aim was to analyse concordance between BRAF IHC and BRAF molecular analysis in a large, mono-institutional CRC whole-slide, case series with laboratory validation.
View Article and Find Full Text PDFDNA Mismatch Repair System Imbalances in Breast Adenocarcinoma.
Cancer Diagn Progn
March 2023
Breast Unit, 1st Department of Obstetrics and Gynaecology, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece.
DNA mismatch repair system (MMR) is considered a leading genetic mechanism in stabilizing DNA structure and maintaining its function. DNA MMR is a highly conserved system in bacteria, prokaryotic, and eukaryotic cells, and provides the highest protection to DNA by repairing micro-structural alterations. DNA MMR proteins are involved in the detection and repair of intra-nucleotide base-to-base errors inside the complementary DNA strand recognizing the recently synthesized strand from the parental template.
View Article and Find Full Text PDFImmune evasion phenotype is common in Richter transformation diffuse large B-cell lymphoma variant.
Virchows Arch
June 2023
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Article Synopsis
- Immune checkpoint inhibitors, specifically PD-1 inhibitors, show potential as a new treatment for patients with Richter transformation-diffuse large B-cell lymphoma variant (RT-DLBCL), based on a study of 64 patients.
- The study categorized tumor expression levels of PD-1, PD-L1, CD30, and microsatellite instability, identifying a subset of patients (43.7%) with an "immune evasion phenotype" (IEP+) that displayed significantly higher levels of PD1-positive tumor-infiltrating lymphocytes (TILs).
- Patients with brisk PD1+ TILs had a notably better overall survival rate compared to those with lower levels of TILs, indicating a correlation between immune response
The Effect of Tobacco Smoke -Nitrosamines, NNK and NDEA, and Nicotine, on DNA Mismatch Repair Mechanism and miRNA Markers, in Hypopharyngeal Squamous Cell Carcinoma: An In Vivo Model and Clinical Evidence.
Curr Oncol
August 2022
The Yale Larynx Laboratory, Department of Surgery, Yale School of Medicine, New Haven, CT 06510, USA.
Deregulation of the DNA mismatch repair (MMR) mechanism has been linked to poor prognosis of upper aerodigestive tract cancers. Our recent in vitro data have provided evidence of crosstalk between deregulated miRNAs and MMR genes, caused by tobacco smoke (TS) -Nitrosamines, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in hypopharyngeal cells. Here, we explored whether chronic exposure to TS components can affect MMR mechanism and miRNA profiles in hypopharyngeal mucosa.
View Article and Find Full Text PDFMismatch repair system in colorectal cancer. Frequency, cancer phenotype, and follow-up.
Rev Gastroenterol Mex (Engl Ed)
November 2022
Departamento de Patología, Instituto Nacional de Ciencias Médicas y Nutrición «Salvador Zubirán», Mexico City, Mexico. Electronic address:
Introduction And Aims: A frequent task in the study of colorectal carcinomas (CRC) is to identify tumors harboring deficient DNA mismatch repair systems (dMMR), which are associated with microsatellite instability. Given that there is scant information on those tumors in Mexican patients, our aim was to describe their frequency, clinical and pathologic characteristics, and results, which are necessary for future trials.
Materials And Methods: A consecutive series of CRC patients, treated and followed at a tertiary care center was performed.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!